Photo credit: mos.ru
The new Russian-Japanese test system will be put into practice in April, the Izvestia newspaper reports, citing the Russian Direct Investment Fund.
The Evotech-Mirai Genomix test system, developed by EMG company, makes it possible to identify COVID-19 in almost a hundred percent of cases within half an hour, and in the early stages. Tests were probed by Rospotrebnadzor and approved for use in Russia. Moscow and the Moscow Region are to become the starting regions, after that the tests will be distributed throughout the country.
Currently, three test systems are used in Russia, but the new system surpasses them in accuracy and speed, says Alexander Lukashev, head of the Institute of Medical Parasitology, Tropical and Vector-borne Diseases of Martsinovsky Sechenovskiy University. According to experts, the technology used in the new test systems is not inferior to the existing ones. Besides that, it reduces the testing time by more than four times.
Highly accurate and affordable tests that help identify infected people will help Russia cope with coronavirus infection more successfully, experts are convinced.
In addition, the tests of the vaccine against the new coronavirus on rodents have been completed, and now it will have to be tested on primates, Interfax wirtes. Animal tests should be completed by the end of April, says Rinat Maksyutov, who holds the post of director of the Vektor State Scientific Center. The vaccine may be tested on humans already in June.
Russkiy Mir
